Thomas T Amatruda

Author PubWeight™ 7.08^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.	Clin Cancer Res	2006	1.72
2	Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.	J Clin Oncol	2005	1.37
3	Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.	Clin Cancer Res	2010	1.19
4	Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.	J Clin Oncol	2006	1.03
5	Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.	J Immunother	2012	0.90
6	A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.	Cancer	2012	0.88